Merve Gulbiz Dagoglu Kartal

Merve Gulbiz Dagoglu Kartal

Auto-generated profile, based on publicly available information

Merve Gulbiz Dagoglu Kartal

Department of Radiology, Istanbul Faculty of Medicine, Istanbul University, Istanbul 34093, Turkey

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2024 in Diagnostic and Interventional Radiology
Verified
Journal Article
Open access
HAHakan Ayyildiz
Hakan Ayyildiz
OIOkan İnCe
Okan İnCe
EKEsin Korkut
Esin Korkut
MKMerve Gülbiz Dağoğlu Kartal
Merve Gülbiz Dağoğlu Kartal
ATAtadan Tunacı
Atadan Tunacı
SESukru Mehmet Erturk
Sukru Mehmet Erturk
Machine learning models for discriminating clinically significant from clinically insignificant prostate cancer using bi-parametric magnetic resonance imaging - Diagnostic and Interventional Radiology

1 May 2023 in Diagnostic and Interventional Radiology
Verified
Journal Article
Open access
MOMehmet Ruhi Onur
Mehmet Ruhi Onur
YOYakup Ozbay
Yakup Ozbay
IIİlkay İdilman
İlkay İdilman
AKAli Devrim Karaosmanoğlu
Ali Devrim Karaosmanoğlu
SRSelma Uysal Ramadan
Selma Uysal Ramadan
MKMuşturay Karçaaltıncaba
Muşturay Karçaaltıncaba
To evaluate the frequency of abdominal computed tomography (CT) findings in patients with coronavirus disease-2019 (COVID-19) and interrogate the relationship between abdominal CT findings and patient demographic features, clinical findings, and laboratory test results as well as the CT atherosclerosis score in the abdominal aorta. This study was designed as a multicenter retrospective study. The abdominal CT findings of 1.181 patients with positive abdominal symptoms from 26 tertiary medical centers with a positive polymerase chain-reaction test for severe acute respiratory syndrome coronavirus 2 were reviewed. The frequency of ischemic and non-ischemic CT findings as well as the association between CT findings, clinical features, and abdominal aortic calcific atherosclerosis score (AA-CAS) were recorded. Ischemic and non-ischemic abdominal CT findings were detected in 240 (20.3%) and 328 (27.7%) patients, respectively. In 147 patients (12.4%), intra-abdominal malignancy was present. The most frequent ischemic abdominal CT findings were bowel wall thickening (n = 120; 10.2%) and perivascular infiltration (n = 40; 3.4%). As for non-ischemic findings, colitis (n = 91; 7.7%) and small bowel inflammation (n = 73; 6.2%) constituted the most frequent disease processes. The duration of hospital stay was found to be higher in patients with abdominal CT findings than in patients without any positive findings (13.8 ± 13 vs. 10.4 ± 12.8 days, P < 0.001). The frequency of abdominal CT findings was significantly higher in patients who did not survive the infection than in patients who were discharged after recovery (41.7% vs. 27.4%, P < 0.001). Increased AA-CAS was found to be associated with a higher risk of ischemic conditions in abdominal CT examinations. Abdominal symptoms in patients with COVID-19 are usually associated with positive CT findings. The presence of ischemic findings on CT correlates with poor COVID-19 outcomes. A high AA-CAS is associated with abdominal ischemic findings in patients with COVID-19.

1 September 2026 in Cancers
Verified
Journal Article
Open access
PDF file
HAHalil Ertugrul Aktas
Halil Ertugrul Aktas
ETEminenur Sen Tasci
Eminenur Sen Tasci
LPLinkai Peng
Linkai Peng
MTMuhammed Enes Tasci
Muhammed Enes Tasci
YTYavuz B. Taktak
Yavuz B. Taktak
UBUlas Bagci
Ulas Bagci
Background: Accurate pancreatic tumor segmentation on contrast-enhanced computed tomography (CECT) is important for staging, treatment planning, and response assessment in pancreatic ductal adenocarcinoma (PDAC). Although foundation models have shown promise for medical image segmentation, their effectiveness for disease-specific tumor delineation remains uncertain. This study evaluated whether fine-tuning a Segment Anything Model (SAM)-based framework on the target cohorts improves pancreatic tumor segmentation compared with directly applied foundation models. Methods: In this retrospective multicenter study, CECT examinations from patients with pathologically confirmed PDAC acquired between 2015 and 2025 were included. Two foundation model baselines, nnInteractive and MedSAM2, were compared with three TAGS-based configurations representing increasing levels of adaptation: TAGS (Zero-Shot), SAM-TAGS (fine-tuned from SAM weights), and MSD-TAGS (fine-tuned from a pancreas-specific checkpoint). Performance was assessed using patient-level five-fold cross-validation with the Dice Similarity Coefficient (DSC) and Normalized Surface Dice (NSD). A leave-one-center-out analysis was additionally performed to evaluate generalization to institutions absent from training. Results: A total of 500 patients with PDAC from four independent centers were included. MSD-TAGS achieved the highest overall segmentation performance, with a mean DSC of 0.703 and a mean NSD of 0.835. SAM-TAGS achieved a mean DSC of 0.691 and a mean NSD of 0.822. In comparison, nnInteractive achieved a mean DSC of 0.632 and a mean NSD of 0.782; MedSAM2, 0.585 and 0.792; and TAGS (Zero-Shot), 0.496 and 0.639, respectively. Compared with each competing method, MSD-TAGS achieved significantly higher DSC and NSD values (all Holm-adjusted p < 0.001). It also achieved the highest DSC across all four centers and the highest NSD in three of the four centers. Under leave-one-center-out evaluation, MSD-TAGS declined by 0.025 DSC and SAM-TAGS by 0.089. Conclusions: Task-specific adaptation improved pancreatic tumor segmentation with foundation models, and fine-tuned TAGS outperformed two publicly released promptable models applied without adaptation. Models initialized from a pancreas-specific checkpoint showed greater robustness under center-held-out evaluation. These findings support the importance of organ-specific initialization and target-cohort fine-tuning for disease-specific segmentation and warrant further validation before clinical translation. The multicenter pancreatic tumor CT segmentation dataset, including de-identified images and expert segmentation annotations, is publicly available to facilitate future research.

13 June 2024 in Current Medical Imaging
Verified
Journal Article
Open access
PDF file
ECEda Cingoz
Eda Cingoz
GEGokhan Ertas
Gokhan Ertas
GKGizem Kaval
Gizem Kaval
SASena Azamat
Sena Azamat
SKSule Karaman
Sule Karaman
MKMerve Gulbiz Dagoglu Kartal
Merve Gulbiz Dagoglu Kartal
Introduction:: The aim of the study was to develop deep-learning neural networks to guide treatment decisions and for the accurate evaluation of tumor response to neoadjuvant chemoradiotherapy (nCRT) in rectal cancer using magnetic resonance (MR) images. Methods:: Fifty-nine tumors with stage 2 or 3 rectal cancer that received nCRT were retrospectively evaluated. Pathological tumor regression grading was carried out using the Dworak (Dw-TRG) guidelines and served as the ground truth for response predictions. Imaging-based tumor regression grading was performed according to the MERCURY group guidelines from pre-treatment and post-treatment para-axial T2-weighted MR images (MR-TRG). Tumor signal intensity signatures were extracted by segmenting the tumors volumetrically on the images. Normalized histograms of the signatures were used as input to a deep neural network (DNN) housing long short-term memory (LSTM) units. The output of the network was the tumor regression grading prediction, DNN-TRG. Results:: In predicting complete or good response, DNN-TRG demonstrated modest agreement with Dw-TRG (Cohen’s kappa= 0.79) and achieved 84.6% sensitivity, 93.9% specificity, and 89.8% accuracy. MR-TRG revealed 46.2% sensitivity, 100% specificity, and 76.3% accuracy. In predicting a complete response, DNN-TRG showed slight agreement with Dw-TRG (Cohen’s kappa= 0.75) with 71.4% sensitivity, 97.8% specificity, and 91.5% accuracy. MR-TRG provided 42.9% sensitivity, 100% specificity, and 86.4% accuracy. DNN-TRG benefited from higher sensitivity but lower specificity, leading to higher accuracy than MR-TRG in predicting tumor response. Conclusion:: The use of deep LSTM neural networks is a promising approach for evaluating the tumor response to nCRT in rectal cancer.

1 October 2025
Verified
Book Chapter
Closed access
ASArtür Salmaslioglu
Artür Salmaslioglu
MKMerve Gulbiz Dagoglu Kartal
Merve Gulbiz Dagoglu Kartal

27 October 2025 in Current Oncology
Verified
Journal Article
Open access
PDF file
KIKamuran Ibis
Kamuran Ibis
MDMustafa Durmaz
Mustafa Durmaz
DYDeniz yanık
Deniz yanık
İBİrem Bünül
İrem Bünül
MDMustafa Denizli
Mustafa Denizli
MEMurat EMEÇ
Murat EMEÇ
Background: This study aims to evaluate the contribution of clinical and radiomic features to machine learning-based models for survival prediction in patients with locally advanced cervical cancer. Methods: Clinical and radiomic data from 161 patients were retrospectively collected from a single center. Radiomic features were obtained from contrast-enhanced magnetic resonance imaging (MRI) T1-weighted (T1W), T2-weighted (T2W), and diffusion-weighted (DWI) sequences. After data cleaning, feature engineering, and scaling, survival prediction models were created using the CatBoost algorithm with different data combinations (clinical, clinical + T1W, clinical + T2W, clinical + DWI). The performance of the models was evaluated using test accuracy, precision, recall, F1-score, ROC curve, and Bland–Altman analysis. Results: Models using both clinical and radiomic features showed significant improvements in accuracy and F1-score compared to models based solely on clinical data. In particular, the CatBoost_CLI + T2W_DMFS model achieved the best performance, with a test accuracy of 92.31% and an F1-score of 88.62 for distant metastasis-free survival prediction. ROC and Bland–Altman analyses further demonstrated that this model has high discriminative power and prediction consistency. Conclusions: The CatBoost algorithm shows high accuracy and reliability for survival prediction in locally advanced cervical cancer when clinical and radiomic features are combined. The addition of radiomics data significantly improves model performance.